CMS Interprets Medicaid Cuts Law Without Cancer Patient Protections Advocates Expected
CMS has issued guidance interpreting recent Medicaid legislation in a manner that cancer patient advocates argue fails to deliver promised protections from coverage cuts. Blood Cancer United's Gwen Nichols warns that vulnerable oncology patients face exposure to benefit reductions or coverage limitations despite congressional assurances. The interpretation affects how states and managed care organizations implement Medicaid changes affecting cancer treatment access and continuity of care. The guidance creates immediate operational uncertainty for MCOs managing oncology benefits and prior authorization protocols.
MCOs must review oncology benefit designs and utilization management protocols to ensure compliance with CMS guidance while managing potential member grievances and continuity of care issues for cancer patients.
Managed Care
You might also like